Try our beta test site

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Centers for Disease Control and Prevention, China.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Centers for Disease Control and Prevention, China
ClinicalTrials.gov Identifier:
NCT01042652
First received: January 4, 2010
Last updated: June 14, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)